This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.
It is no longer the current profile. Read the current profile and its correction notice.
Update · July 27, 2026
We rewrote the profile summary to describe the cited public record more directly. The cited sources and status did not change. 12
What this version reported
The cited DailyMed label identifies Semaglutide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.↗
Organizations named in cited records:
- U.S. National Library of Medicine↗
Sources for this version
- 1WEGOVY (semaglutide) injection and tablet · SPL version 19 · published 2026-06-30 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 2FDA approves higher-dose semaglutide ↗
U.S. Food and Drug Administration · Official source · Source checked July 22, 2026